Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2116 to 2130 of 8915 results

  1. Subcutaneous ravulizumab for treating paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome [TSID11820]

    Topic prioritisation

  2. CT-P39 (omalizumab biosimilar) for previously treated chronic spontaneous urticaria [TSID11832]

    Topic prioritisation

  3. Semaglutide for treating obesity-related heart failure with preserved ejection fraction [TSID11788]

    Topic prioritisation

  4. Subcutaneous efgartigmod for treating generalised myasthenia gravis [TSID11835]

    Topic prioritisation

  5. NPJ5008 for treating malignant hyperthermia [TSID11829]

    Topic prioritisation

  6. Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TSID10639]

    Topic prioritisation

  7. Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]

    Topic prioritisation

  8. Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998]

    Topic prioritisation

  9. High-dose aflibercept for treating wet age-related macular degeneration [TSID10590]

    Topic prioritisation

  10. Transoral Endoscopic Thyroid/Parathyroid Vestibular Approach

    Topic prioritisation

  11. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

  12. Spinal instrumentation with robot assisted navigation

    Topic prioritisation

  13. Oesophageal String Test

    Topic prioritisation

  14. RenalGuard Therapy for reduction in the incidence of Contrast-Associated AKI (CA-AKI) in at-risk patients

    Topic prioritisation

  15. Lymphatico-venous anastomosis for chronic lymphoedema

    Topic prioritisation